Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacology
- 23 July 2008
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 18 (11), 773-786
- https://doi.org/10.1016/j.euroneuro.2008.06.005
Abstract
No abstract availableKeywords
This publication has 220 references indexed in Scilit:
- Post-Pubertal Disruption of Medial Prefrontal Cortical Dopamine–Glutamate Interactions in a Developmental Animal Model of SchizophreniaBiological Psychiatry, 2007
- D2 dopamine receptors recruit a GABA component for their attenuation of excitatory synaptic transmission in the adult rat prefrontal cortexSynapse, 2007
- Altered Prefrontal Cortical Metabolic Response to Mesocortical Activation in Adult Animals with a Neonatal Ventral Hippocampal LesionBiological Psychiatry, 2006
- Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hippocampal neuronsNature Neuroscience, 2005
- Inhibitory interactions of calcineurin (phosphatase 2B) and calmodulin on rat hippocampal NMDA receptorsNeuropharmacology, 2004
- Sequential Regional Cerebral Blood Flow Brain Scans Using PET with H215O Demonstrate Ketamine Actions in CNS DynamicallyNeuropsychopharmacology, 2001
- Myocarditis and Cardiomyopathy Associated with Clozapine Use in the United StatesNew England Journal of Medicine, 2001
- Postnatal development of D 1 dopamine receptors in the medial prefrontal cortex, striatum and nucleus accumbens of normal and neonatal 6-hydroxydopamine treated rats: a quantitative autoradiographic analysisDevelopmental Brain Research, 1991
- Changes in synaptic density in motor cortex of rhesus monkey during fetal and postnatal lifeDevelopmental Brain Research, 1989
- Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activityLife Sciences, 1978